Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 68
2001 182
2002 197
2003 209
2004 205
2005 253
2006 307
2007 317
2008 242
2009 293
2010 302
2011 307
2012 396
2013 454
2014 540
2015 696
2016 684
2017 660
2018 655
2019 634
2020 544
2021 545
2022 526
2023 445
2024 252

Text availability

Article attribute

Article type

Publication date

Search Results

9,409 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab maintenance in patients with myeloma.
Beksac M. Beksac M. Lancet Oncol. 2024 Jun 14:S1470-2045(24)00341-3. doi: 10.1016/S1470-2045(24)00341-3. Online ahead of print. Lancet Oncol. 2024. PMID: 38889736 No abstract available.
Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial.
Moreau P, Hulin C, Perrot A, Arnulf B, Belhadj K, Benboubker L, Zweegman S, Caillon H, Caillot D, Avet-Loiseau H, Delforge M, Dejoie T, Facon T, Sonntag C, Fontan J, Mohty M, Jie KS, Karlin L, Kuhnowski F, Lambert J, Leleu X, Macro M, Orsini-Piocelle F, Roussel M, Schiano de Colella JM, van de Donk NW, Wuillème S, Broijl A, Touzeau C, Tiab M, Marolleau JP, Meuleman N, Vekemans MC, Westerman M, Klein SK, Levin MD, Offner F, Escoffre-Barbe M, Eveillard JR, Garidi R, Hua W, Wang J, Tuozzo A, de Boer C, Rowe M, Vanquickelberghe V, Carson R, Vermeulen J, Corre J, Sonneveld P; Intergroupe Francophone du Myélome, the Dutch-Belgian Cooperative Trial Group for Hematology Oncology and the CASSIOPEIA Investigators. Moreau P, et al. Lancet Oncol. 2024 Jun 14:S1470-2045(24)00282-1. doi: 10.1016/S1470-2045(24)00282-1. Online ahead of print. Lancet Oncol. 2024. PMID: 38889735
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study.
Saha A, Bosma JS, Twilt JJ, van Ginneken B, Bjartell A, Padhani AR, Bonekamp D, Villeirs G, Salomon G, Giannarini G, Kalpathy-Cramer J, Barentsz J, Maier-Hein KH, Rusu M, Rouvière O, van den Bergh R, Panebianco V, Kasivisvanathan V, Obuchowski NA, Yakar D, Elschot M, Veltman J, Fütterer JJ, de Rooij M, Huisman H; PI-CAI consortium. Saha A, et al. Lancet Oncol. 2024 Jun 11:S1470-2045(24)00220-1. doi: 10.1016/S1470-2045(24)00220-1. Online ahead of print. Lancet Oncol. 2024. PMID: 38876123
Cancer updates from the 77th World Health Assembly.
Adepoju P. Adepoju P. Lancet Oncol. 2024 Jun 6:S1470-2045(24)00332-2. doi: 10.1016/S1470-2045(24)00332-2. Online ahead of print. Lancet Oncol. 2024. PMID: 38852603 No abstract available.
New Canadian draft breast screening guidelines issued.
Pellerin R. Pellerin R. Lancet Oncol. 2024 Jun 6:S1470-2045(24)00330-9. doi: 10.1016/S1470-2045(24)00330-9. Online ahead of print. Lancet Oncol. 2024. PMID: 38852602 No abstract available.
Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study.
Yu JH, Xiao BY, Li DD, Jiang W, Ding Y, Wu XJ, Zhang RX, Lin JZ, Wang W, Han K, Kong LH, Zhang XK, Chen BY, Mei WJ, Pan ZZ, Tang JH, Zhang XS, Ding PR. Yu JH, et al. Lancet Oncol. 2024 Jun 6:S1470-2045(24)00203-1. doi: 10.1016/S1470-2045(24)00203-1. Online ahead of print. Lancet Oncol. 2024. PMID: 38852601
9,409 results